Subsequently, five genes (C6, UGT2B7, SLC22A1, F11, and CYP2C8) were identified as potential novel diagnostic biomarkers and four genes (CYS2, F11, ANXA10, and SLC22A1) were identified as potential novel prognostic biomarkers in HCC. Here, UGT2B7 is linked to hepatocellular carcinoma.